Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Virtual vs Traditional Study Conduct in T1DM
NCT03260868Phase 4Terminated
- Sponsor
- Sanofi
- Start
- Sep 2017
- Primary completion
- Nov 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 4 trial of insulin glargine in type 1 diabetes mellitus (T1D), sponsored by Sanofi. Started Sep 2017; status: terminated.
02
Drugs
insulin glargine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03260868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03260868.